Coherus BioSciences News

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Acadia Healthcare (ACHC) and Coherus Biosciences (CHRS)

TipRanksApr 15 04:30 ET

Coherus BioSciences Analyst Ratings

BenzingaMar 20 07:17 ET

Buy Rating on Coherus Biosciences: Balancing Divestiture With Promising Pipeline and Financial Growth

TipRanksMar 20 06:16 ET

Coherus Biosciences: Strong Q4 Performance and Strategic Moves Merit Outperform Rating

TipRanksMar 15 01:36 ET

Analysts Offer Insights on Healthcare Companies: Coherus Biosciences (CHRS) and Solid Biosciences (SLDB)

TipRanksMar 14 20:30 ET

Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Coherus Biosciences (CHRS) and Autolus Therapeutics (AUTL)

TipRanksMar 14 13:40 ET

Coherus BioSciences Analyst Ratings

BenzingaMar 14 07:31 ET

Buy Rating Affirmed for Coherus Biosciences on Strong Sales and Strategic Restructuring

TipRanksMar 14 06:15 ET

Barclays Sticks to Their Buy Rating for Coherus Biosciences (CHRS)

TipRanksJan 29 05:07 ET

Coherus BioSciences Analyst Ratings

BenzingaJan 23 15:04 ET

Coherus BioSciences Analyst Ratings

BenzingaJan 23 07:49 ET

Barclays Gives a Buy Rating to Coherus Biosciences (CHRS)

TipRanksJan 22 14:42 ET

Buy Rating Affirmed for Coherus Biosciences on Strong Clinical Data and Strategic Pipeline Positioning

TipRanksJan 22 13:29 ET

Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD) and Coherus Biosciences (CHRS)

TipRanksJan 11 06:30 ET

Analysts Offer Insights on Healthcare Companies: Coherus Biosciences (CHRS) and Regeneron (REGN)

TipRanksDec 28, 2023 05:40 ET

Buy Rating Affirmed: Coherus Biosciences's Growth Prospects Bolstered by Udenyca Onbody Injector Approval

TipRanksDec 28, 2023 02:45 ET

Analysts Are Bullish on These Healthcare Stocks: Coherus Biosciences (CHRS), Oncternal Therapeutics (ONCT)

TipRanksDec 27, 2023 06:20 ET

HC Wainwright & Co. Reiterates Buy on Coherus BioSciences, Maintains $13 Price Target

BenzingaDec 27, 2023 06:06 ET

Coherus BioSciences Analyst Ratings

BenzingaDec 27, 2023 06:04 ET

HC Wainwright & Co. Reiterates Buy on Coherus BioSciences, Maintains $13 Price Target

BenzingaDec 7, 2023 06:26 ET